Navidea Biopharmaceuticals, Inc. (NAVB) Social Stream



Navidea Biopharmaceuticals, Inc. (NAVB): $0.67

-0.06 (-7.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NAVB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 493

in industry

Navidea Biopharmaceuticals Inc (NAVB) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NAVB.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-05-14 1 $5 $5 $5 $0.85 488.24%
2021-11-11 2 $8 $5 $6.5 $0.85 664.71%

NAVB reports an average of 291.95% for its upside potential over the past 26 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-14 1 5 5 5.0 1.60 212.5%
2021-05-17 2 8 5 6.5 1.59 308.81%
2021-11-11 2 8 5 6.5 1.43 354.55%

NAVB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NAVB as an investment opportunity.

  • NAVB has a higher number of analysts covering the stock than 4.67% of all US stocks.
  • Navidea Biopharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 193.98% of all US stocks.
  • NAVB has a higher average analyst price target than 7.3% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Navidea Biopharmaceuticals Inc's variance in analysts' estimates is lower than 36.98% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Navidea Biopharmaceuticals Inc are LHDX, AWH, and ACHV.

Is NAVB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5207 seconds.